-
Mix and Match vaccine highly effective against Covid-19
They said that the risk reduction was 50 for people having received two doses of the AstraZeneca vaccine which is known as Covishield in India
-
Pfizer and AstraZeneca less effective against Delta variant
Delta infections after two vaccine doses had similar peak levels of virus as those in unvaccinated people, the researchers said
-
Talks with foreign vaccine makers stuck on indemnity clause
The foreign vaccine makers are demanding indemnity against legal liability in case of adverse reactions post-vaccination.
-
Covid-19: Moderna’s vaccine delivery gets delayed in India
The supply of Moderna vaccines is expected in 2022 as orders are totally booked for the current year.
-
Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India
Moderna through a separate communication has informed that the US government has agreed to donate a certain number of doses to the Indian government.
-
Moderna seeks regulatory approval for its Covid-19 vaccine
The US Government has agreed to donate a certain number of doses of the Moderna COVID-19 vaccine through COVAX to the Government of India
-
G-7 nations pledge 1 billion vaccine doses for world
G-7 leaders' summit is set to formally embrace a global minimum tax of at least 15% on corporations.
-
Moderna seeks to use vaccine for adolescents
Moderna said it had filed data for a conditional marketing approval in the 27-nation EU bloc to expand its coronavirus vaccine to children, beyond the
-
Covid-19: Vietnam finds new virus variant, hybrid of India, UK strains
Viruses often develop small genetic changes as they reproduce, and new variants of the coronavirus have been seen almost since it was first detected i
-
Moderna’s single-dose vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021
The Health Ministry has also been asked to take an early decision on Cipla's request regarding support required by them for procurement of Moderna vac
